1. A prospective trial comparing FDG‐PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck. (1st August 2014) Authors: Adkins, Douglas; Ley, Jessica; Dehdashti, Farrokh; Siegel, Marilyn J.; Wildes, Tanya M.; Michel, Loren; Trinkaus, Kathryn; Siegel, Barry A. Journal: Cancer medicine Issue: Volume 3:Number 6(2014:Dec.) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer center. Issue 1 (27th February 2021) Authors: Kang, Jung Julie; Tchekmedyian, Vatche; Mohammed, Nader; Rybkin, Alisa; Kitpanit, Sarin; Fan, Ming; Wang, Huili; Lobaugh, Stephanie M.; Zhang, Zhigang; Lee, Anna; Chen, Linda; Yu, Yao; Zakeri, Kaveh; Gelblum, Daphna Y.; Riaz, Nadeem; McBride, Sean M.; Tsai, C. Jillian; Cohen, Marc A.; Cracchiolo,... Journal: International journal of cancer Issue: Volume 149:Issue 1(2021) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Looking beyond the CRT paradigm: Why induction chemotherapy is worthy of pursuit. Issue 2 (February 2015) Authors: Adkins, Douglas; Ley, Jessica; Michel, Loren; Wildes, Tanya M.; Thorstad, Wade; Rich, Jason; Nussenbaum, Brian Journal: Oral oncology Issue: Volume 51:Issue 2(2015:Feb.) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma. (October 2016) Authors: Adkins, Douglas; Ley, Jessica; Michel, Loren; Wildes, Tanya M.; Thorstad, Wade; Gay, Hiram A.; Daly, Mackenzie; Rich, Jason; Paniello, Randal; Uppaluri, Ravindra; Jackson, Ryan; Trinkaus, Kathryn; Nussenbaum, Brian Journal: Oral oncology Issue: Volume 61(2016:Oct.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma. (October 2016) Authors: Adkins, Douglas; Ley, Jessica; Michel, Loren; Wildes, Tanya M.; Thorstad, Wade; Gay, Hiram A.; Daly, Mackenzie; Rich, Jason; Paniello, Randal; Uppaluri, Ravindra; Jackson, Ryan; Trinkaus, Kathryn; Nussenbaum, Brian Journal: Oral oncology Issue: Volume 61(2016:Oct.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nab‐paclitaxel‐based compared to docetaxel‐based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck. (26th January 2015) Authors: Schell, Amy; Ley, Jessica; Wu, Ningying; Trinkaus, Kathryn; Wildes, Tanya Marya; Michel, Loren; Thorstad, Wade; Gay, Hiram; Lewis, James; Rich, Jason; Diaz, Jason; Paniello, Randal C.; Nussenbaum, Brian; Adkins, Douglas R. Journal: Cancer medicine Issue: Volume 4:Number 4(2015:Apr.) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3‐dimensional conformal or intensity‐modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies. Issue 9 (25th February 2020) Authors: Fan, Ming; Kang, Jung Julie; Lee, Anna; Fan, Dan; Wang, Huili; Kitpanit, Sarin; Fox, Pamela; Sine, Kevin; Mah, Dennis; McBride, Sean M.; Tsai, Chiaojung Jillian; Riaz, Nadeem; Dunn, Lara A.; Sherman, Eric J.; Michel, Loren; Singh, Bhuvanesh; Ganly, Ian; Wong, Richard J.; Boyle, Jay O.; Cohen, Mar... Journal: Cancer Issue: Volume 126:Issue 9(2020) Page Start: 1905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. (July 2016) Authors: Michel, Loren; Ley, Jessica; Wildes, Tanya M.; Schaffer, András; Robinson, Anthony; Chun, Se-Eun; Lee, Wooin; Lewis, James; Trinkaus, Kathryn; Adkins, Douglas Journal: Oral oncology Issue: Volume 58(2016:Jul.) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗